The Impact of Rees Scientific’s Continuous Monitoring Systems in Pharmaceutical and Biotech Companies

Feature
Video
Conference|INTERPHEX

Josh Hirshenhorn (Sales Representative, Rees Scientific) explains current challenges faced by pharmaceutical and biotech companies and how Rees' continuous monitoring systems offer solutions.

Josh Hirshenhorn sat down with Pharmaceutical Technology to discuss Rees Scientific's evolution in the market. Learn more about:

  • How real-time monitoring of critical environment conditions allows Rees to ensure customers that their products are stored and handled under optimal conditions.
  • The ease of integration for their monitoring systems into any existing infrastructure.
  • The importance of temperature mapping and how that helps to protect the efficacy of a product.
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
The show floor at INTERPHEX 2025. | Image Credit: © Patrick Lavery/PharmTech Group

Recapping INTERPHEX 2025: Pharma Looks Toward the Future

Patrick Lavery
April 4th 2025
Article

The yearly convention in New York City showcased new and emerging technologies and gave participating exhibitors a chance to unveil their strategies for the second half of the 2020s.

How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)

How Changing Regulations Impact Pharmaceutical Film Coating Formulations (AAPS 2022)

Chris Spivey
November 29th 2022
Podcast

Allison Labriola, Senior Technical Sales Representative, at JRS Pharma is interviewed by the Editorial Director of Pharmaceutical Technology Chris Spivey about how the food industry is affecting the pharmaceutical industry.

INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption

INTERPHEX 2025: Industry Initiates Interchangeable Single-Use Assembly Components in Response to COVID-19 Supply-Chain Disruption

Patrick Lavery;Feliza Mirasol
April 3rd 2025
Article

Sitting down with the PharmTech Group at INTERPHEX 2025, Nicole Hunter, head of Global WMArchitect at WMFTS, explains the industry initiative around single-use assembly components resulting from supply disruptions caused by the COVID-19 pandemic.

INTERPHEX 2025: Innovations in Advanced Sensing Technologies that Answer the Need for Reliable Valve Function

INTERPHEX 2025: Innovations in Advanced Sensing Technologies that Answer the Need for Reliable Valve Function

Patrick Lavery;Feliza Mirasol
April 3rd 2025
Article

Speaking with the PharmTech Group at INTERPHEX 2025, Dave Loula, global product director, ITT Engineered Valves, discusses innovation in advanced sensing technologies that addresses customer need for reliable valve function.

INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing

INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing

Patrick Lavery;Feliza Mirasol
April 2nd 2025
Article

Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.

INTERPHEX 2025: How Functional Labeling Can Protect Parentals in Vials and Syringes

INTERPHEX 2025: How Functional Labeling Can Protect Parentals in Vials and Syringes

Patrick Lavery;Feliza Mirasol
April 1st 2025
Article

William Wainwright, business development manager at Iwata Label USA, discusses the practical security benefits of functional labels at INTERPHEX 2025.